Two major constituents of cannabis are Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the main psychoactive component; CBD may buffer the user against the harmful effects of THC.
Aims:
We examined the effects of two strains of cannabis and placebo on the human brain’s resting-state networks using fMRI.
Methods:
Seventeen healthy volunteers (experienced with cannabis, but not regular users) underwent three drug treatments and scanning sessions. Treatments were cannabis containing THC (Cann−CBD; 8 mg THC), cannabis containing THC with CBD (Cann+CBD; 8 mg THC + 10 mg CBD), and matched placebo cannabis. Seed-based resting-state functional connectivity analyses were performed on three brain networks: the default mode (DMN; defined by positive connectivity with the posterior cingulate cortex: PCC+), executive control (ECN; defined by negative connectivity with the posterior cingulate cortex: PCC−) and salience (SAL; defined by positive connectivity with the anterior insula: AI+) network.
Results:
Reductions in functional connectivity (relative to placebo) were seen in the DMN (PCC+) and SAL (AI+) networks for both strains of cannabis, with spatially dissociable effects. Across the entire salience network (AI+), Cann−CBD reduced connectivity relative to Cann+CBD. The PCC in the DMN was specifically disrupted by Cann−CBD, and this effect correlated with subjective drug effects, including feeling ‘stoned’ and ‘high’.
Conclusions:
THC disrupts the DMN, and the PCC is a key brain region involved in the subjective experience of THC intoxication. CBD restores disruption of the salience network by THC, which may explain its potential to treat disorders of salience such as psychosis and addiction.
BenjaminiYHochbergY (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc57: 289–300.
2.
BergamaschiMMQueirozRHCChagasMHNet al. (2011) Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology36: 1219–1226.
3.
BhattacharyyaSCrippaJAAllenPet al. (2012) Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch Gen Psychiatry69: 27–36.
4.
BhattacharyyaSFalkenbergIMartin-SantosRet al. (2014) Cannabinoid modulation of functional connectivity within regions processing attentional salience. Neuropsychopharmacology40: 1343–1352.
5.
BhattacharyyaSMorrisonPDFusar-PoliPet al. (2010) Opposite effects of Δ-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology35: 764–774.
6.
BiswalBBMennesMZuoX-Net al. (2010) Toward discovery science of human brain function. Proc Natl Acad Sci U S A107: 4734–4739.
7.
BossongMGJansmaJMvan HellHHet al. (2013) Default mode network in the effects of Δ9-Tetrahydrocannabinol (THC) on human executive function. PLoS One8: 1–10.
8.
BossongMGVan BerckelBNMBoellaardRet al. (2009) Δ9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology34: 759–766.
9.
BourkeJHWallMB (2015) phMRI: Methodological considerations for mitigating potential confounding factors. Front Neurosci9: 1–7.
10.
BucknerRLAndrews-HannaJRSchacterDL (2008) The brain’s default network: Anatomy, function, and relevance to disease. Ann N Y Acad Sci1124: 1–38.
11.
BurnsHDVan LaereKSanabria-BohórquezSet al. (2007) [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad Sci U S A104: 9800–9805.
12.
Carhart-HarrisRLKevinMRobertLet al. (2015) The effects of acute administered 3,4-methylenedioxymethamphetamine on spontaneous brain function in healthy volunteers measured with arterial spin labelling and blood oxygen level-dependent resting-state functional connectivity. Biol Psychiatry78: 554–562.
13.
ColeDMSmithSMBeckmannCF (2010) Advances and pitfalls in the analysis and interpretation of resting-state FMRI data. Front Syst Neurosci4: 8.
14.
ComninosANDemetriouLWallMBet al. (2018) Modulations of human resting brain connectivity by kisspeptin enhance sexual and emotional functions. JCI Insight3. pii: 121958.
15.
CurranHVBrignellCFletcherSet al. (2002) Cognitive and subjective dose-response effects of acute oral Δ9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology164: 61–70.
16.
CurranHVFreemanTPMokryszCet al. (2016) Keep off the grass? Cannabis, cognition and addiction. Nat Rev Neurosci17: 293–306.
17.
De LucaMBeckmannCFDe StefanoNet al. (2006) fMRI resting state networks define distinct modes of long-distance interactions in the human brain. Neuroimage29: 1359–1367.
18.
DemetriouLKowalczykOSTysonGet al. (2018) A comprehensive evaluation of increasing temporal resolution with multiband-accelerated sequences and their effects on statistical outcome measures in fMRI. Neuroimage176: 404–416.
19.
DemirakcaTSartoriusAEndeGet al. (2011) Diminished gray matter in the hippocampus of cannabis users: Possible protective effects of cannabidiol. Drug Alcohol Depend114: 242–245.
20.
Di FortiMMorganCDazzanPet al. (2009) High potency cannabis and the risk of psychosis. Br J Psychiatry195: 488–491.
21.
D’SouzaDCPerryEMacDougallLet al. (2004) The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology29: 1558–1572.
22.
ElSohlyMAMehmedicZFosterSet al. (2016) Changes in cannabis potency over the last 2 decades (1995–2014): Analysis of current data in the United States. Biol Psychiatry79: 613–619.
FoxMDRaichleME (2007) Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci8: 700–711.
25.
FoxMDSnyderAZVincentJLet al. (2005) The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci U S A102: 9673–9678.
26.
FreemanTPWinstockAR (2015) Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychol Med45: 3181–3189.
27.
FreemanTPMorganCJAHindochaCet al. (2014) Just say ‘know’: How do cannabinoid concentrations influence users’ estimates of cannabis potency and the amount they roll in joints?Addiction109: 1686–1694.
28.
FreemanTPPopeRAWallMBet al. (2017) Cannabis dampens the effects of music in brain regions sensitive to reward and emotion. Int J Neuropsychopharmacol21: 21–32.
29.
FreemanTPvan der PolPKuijpersWet al. (2018) Changes in cannabis potency and first-time admissions to drug treatment: A 16-year study in the Netherlands. Psychol Med48: 2346–2352.
30.
GouldenNKhusnulinaADavisNJet al. (2014) The salience network is responsible for switching between the default mode network and the central executive network: Replication from DCM. Neuroimage99: 180–190.
31.
GrimmOLöfflerMKampingSet al. (2018) Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity. Euro Neuropsychopharmacol28: 841–849.
32.
HindochaCFreemanTPSchaferGet al. (2015) Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users. Euro Neuropsychopharmacol25: 325–334.
33.
HindochaCWollenbergOCarter LenoVet al. (2014) Emotional processing deficits in chronic cannabis use: A replication and extension. J Psychopharmacol28: 466–471.
34.
HirvonenJGoodwinRSLiC-Tet al. (2012) Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry17: 642–649.
35.
IannettiGDWiseRG (2007) BOLD functional MRI in disease and pharmacological studies: Room for improvement?Magn Reson Imaging25: 978–988.
36.
KaelenMRosemanLKahanJet al. (2016) LSD modulates music-induced imagery via changes in parahippocampal connectivity. Euro Neuropsychopharmacol26: 1099–1109.
37.
KapurS (2003) Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry160: 13–23.
38.
KlumpersLEColeDMKhalili-MahaniNet al. (2012) Manipulating brain connectivity with δ9-tetrahydrocannabinol: A pharmacological resting state FMRI study. Neuroimage63:1701–1711.
39.
LawnWFreemanTPPopeRAet al. (2016) Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: An evaluation of the cannabis ‘amotivational’ hypotheses. Psychopharmacology233: 3537–3552.
40.
LewekeFMPiomelliDPahlischFet al. (2012) Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry2: e94.
41.
MokryszCFreemanTPKorkkiSet al. (2016) Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males. Transl Psychiatry6: e961.
42.
MorganCJACurranHV (2008) Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. Br J Psychiatry192: 306–307.
43.
MorganCJAFreemanTPSchaferGLet al. (2010) Cannabidiol attenuates the appetitive effects of Δ9-tetrahydrocannabinol in humans smoking their chosen cannabis. Neuropsychopharmacology35: 1879–1885.
44.
MorganCJAGardenerCSchaferGet al. (2012) Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. Psychol Med42: 391–400.
45.
MorganCJAPageESchaeferCet al. (2013) Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms. Br J Psychiatry202: 381–382.
46.
NiesinkRJMvan LaarMW (2013) Does cannabidiol protect against adverse psychological effects of THC?Front Psychiatry4: 130.
47.
NiesinkRJMRigterSKoeterMWet al. (2015) Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005–15. Addiction110: 1941–1950.
48.
OrrCMoriokaRBehanBet al. (2013) Altered resting-state connectivity in adolescent cannabis users. Am J Drug Alcohol Abuse39: 372–381.
49.
PassowSSpechtKAdamsenTCet al. (2015) Default-mode network functional connectivity is closely related to metabolic activity. Hum Brain Mapp36: 2027–2038.
50.
PertweeRG (2008) The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. Br J Pharmacol153: 199–215.
51.
RamaekersJGKauertGVan RuitenbeekPet al. (2006) High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology31: 2296–2303.
52.
RamaekersJGvan WelJHSpronkDet al. (2016) Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes. Brain Imaging Behav10: 1254–1263.
53.
RobinsonTBerridgeK (1993) The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Rev8: 247–291.
54.
RobinsonTEBerridgeKC (2001) Incentive-sensitization and addiction. Addiction96: 103–114.
55.
RzepaETudgeLMcCabeC (2016) The CB1 neutral antagonist tetrahydrocannabivarin reduces default mode network and increases executive control network resting state functional connectivity in healthy volunteers. Int J Neuropsychopharmacol19: pyv092.
56.
SeeleyWWMenonVSchatzbergAFet al. (2007) Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci27: 2349–2356.
57.
SmithSMFoxPTMillerKLet al. (2009) Correspondence of the brain’s functional architecture during activation and rest. Proc Natl Acad Sci U S A106: 13040–13045.
58.
SridharanDLevitinDJMenonV (2008) A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks. Proc Natl Acad Sci U S A105:12569–12574.
59.
van HellHHBossongMGJagerGet al. (2011) Evidence for involvement of the insula in the psychotropic effects of THC in humans: A double-blind, randomized pharmacological MRI study. Int J Neuropsychopharmacol14: 1377–1388.
60.
Winton-BrownTTAllenPBhattacharyyaSet al. (2011) Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: An fMRI study. Neuropsychopharmacology36: 1340–1348.
61.
YücelMLorenzettiVSuoCet al. (2016) Hippocampal harms, protection and recovery following regular cannabis use. Trans Psychiatry6: e710.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
